Honorable Tom Oliverson, Chair, House Committee on Insurance
FROM:
Jerry McGinty, Director, Legislative Budget Board
IN RE:
HB907 by Johnson, Julie (Relating to prior authorization for prescription drug benefits related to the treatment of autoimmune diseases.), Committee Report 1st House, Substituted
No significant fiscal implication to the State is anticipated.
The bill would amend the Insurance Code to prohibit a health benefit plan issuer that provides drug benefits from requiring more than one prior authorization of a prescription drug prescribed to treat autoimmune diseases. The bill takes effect September 1, 2021 and applies to health plans renewed on or after January 1, 2022.
Based on information provided by the Texas Department of Insurance, Employees Retirement System, and Teacher Retirement System, this analysis assumes that the duties and responsibilities associated with implementing the provisions of the bill could be accomplished by utilizing existing resources.
Local Government Impact
The fiscal implications of the bill cannot be determined at this time.
Source Agencies:
323 Teacher Retirement System, 327 Employees Retirement System, 454 Department of Insurance, 529 Hlth & Human Svcs Comm, 710 Texas A&M Univ System Admin, 720 UT Sys Admin